MetLife Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Sell |
150,974
-232
| -0.2% | -$399 | ﹤0.01% | 2041 |
|
|
2025
Q1 | $504K | Sell |
151,206
-14,636
| -9% | -$48.7K | ﹤0.01% | 1726 |
|
|
2024
Q4 | $1.23M | Buy |
165,842
+19,426
| +13% | +$144K | 0.01% | 1312 |
|
|
2024
Q3 | $1.37M | Hold |
146,416
| – | – | 0.01% | 1210 |
|
|
2024
Q2 | $1.17M | Buy |
146,416
+25,310
| +21% | +$203K | 0.01% | 1260 |
|
|
2024
Q1 | $1.79M | Hold |
121,106
| – | – | 0.01% | 1000 |
|
|
2023
Q4 | $985K | Hold |
121,106
| – | – | 0.01% | 1301 |
|
|
2023
Q3 | $551K | Buy |
121,106
+11,390
| +10% | +$51.8K | ﹤0.01% | 1574 |
|
|
2023
Q2 | $772K | Buy |
109,716
+31,145
| +40% | +$219K | 0.01% | 1420 |
|
|
2023
Q1 | $480K | Hold |
78,571
| – | – | ﹤0.01% | 1673 |
|
|
2022
Q4 | $502K | Hold |
78,571
| – | – | ﹤0.01% | 1644 |
|
|
2022
Q3 | $753K | Hold |
78,571
| – | – | 0.01% | 1344 |
|
|
2022
Q2 | $867K | Buy |
78,571
+73,566
| +1,470% | +$812K | 0.01% | 1286 |
|
|
2022
Q1 | $83.3K | Buy |
+5,005
| New | +$83.3K | ﹤0.01% | 2645 |
|
|
2020
Q2 | – | Sell |
-49,133
| Closed | -$1.47M | – | 2326 |
|
|
2020
Q1 | $1.47M | Sell |
49,133
-2,460
| -5% | -$73.6K | 0.02% | 738 |
|
|
2019
Q4 | $1.43M | Hold |
51,593
| – | – | 0.01% | 939 |
|
|
2019
Q3 | $939K | Buy |
51,593
+3,281
| +7% | +$59.7K | 0.01% | 1102 |
|
|
2019
Q2 | $1.18M | Hold |
48,312
| – | – | 0.01% | 1029 |
|
|
2019
Q1 | $459K | Hold |
48,312
| – | – | 0.01% | 1504 |
|
|
2018
Q4 | $428K | Buy |
48,312
+9,549
| +25% | +$84.5K | 0.01% | 1461 |
|
|
2018
Q3 | $436K | Buy |
+38,763
| New | +$436K | ﹤0.01% | 1616 |
|